Updated Jul 16, 2026
Stergiou Angelos M. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | SLS | SELLAS Life Sciences Group, Inc. | A — Grant or award | 1.06M | $0.00 | |
| 2025-12-05 | SLS | SELLAS Life Sciences Group, Inc. | J — Other acquisition / disposition | 187.1K | $1.50 | $281K |
| 2024-12-05 | SLS | SELLAS Life Sciences Group, Inc. | J — Other acquisition / disposition | 28.3K | $1.13 | $32K |
Stergiou Angelos M. is a corporate insider — currently tracked as President and CEO, Director of SELLAS Life Sciences Group, Inc. (SLS). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Stergiou Angelos M. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.